AHCO
Income statement / Annual
Last year (2023), AdaptHealth Corp.'s total revenue was $3.20 B,
an increase of 7.73% from the previous year.
In 2023, AdaptHealth Corp.'s net income was -$678.90 M.
See AdaptHealth Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.20 B
|
$2.97 B
|
$2.45 B
|
$1.06 B
|
$529.64 M
|
$345.28 M
|
$192.56 M
|
$174.32 M
|
| Cost of Revenue |
$2.72 B |
$2.55 B |
$2.01 B |
$895.16 M |
$439.85 M |
$285.20 M |
$162.90 M |
$158.69 M |
| Gross Profit |
$479.56 M |
$417.43 M |
$445.61 M |
$161.23 M |
$89.80 M |
$60.08 M |
$29.66 M |
$15.63 M |
| Gross Profit Ratio |
0.15 |
0.14 |
0.18 |
0.15 |
0.17 |
0.17 |
0.15 |
0.09 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$310,000.00
|
$0.00
|
| General & Administrative
Expenses |
$190.09 M
|
$162.13 M
|
$167.51 M
|
$89.35 M
|
$56.49 M
|
$1.04 M
|
$9.00 M
|
$8.00 M
|
| Selling & Marketing
Expenses |
$0.00
|
$19.20 M
|
$18.50 M
|
$5.30 M
|
-$12.13 M
|
$1.79 M
|
$482,738.00
|
$399,232.00
|
| Selling, General &
Administrative Expenses |
$190.09 M
|
$162.13 M
|
$167.51 M
|
$89.35 M
|
$44.36 M
|
$1.04 M
|
$693.00
|
$11.40 M
|
| Other Expenses |
$887.87 M |
$64.89 M |
$52.50 M |
-$2.90 M |
$135,000.00 |
$197,592.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$1.08 B |
$227.02 M |
$220.01 M |
$86.44 M |
$44.36 M |
$1.23 M |
$693.00 |
$13.30 M |
| Cost And Expenses |
$3.80 B |
$2.78 B |
$2.23 B |
$981.60 M |
$157.70 M |
$1.23 M |
$693.00 |
$171.99 M |
| Interest Income |
$0.00 |
$109.41 M |
$95.20 M |
$41.43 M |
$39.30 M |
$4.15 M |
$0.00 |
$5.76 M |
| Interest Expense |
$130.30 M |
$109.41 M |
$95.20 M |
$41.43 M |
$13.26 M |
$4.15 M |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$420.59 M
|
$423.44 M
|
$333.18 M
|
$82.45 M
|
$62.57 M
|
$50.61 M
|
$27.82 M
|
$26.56 M
|
| EBITDA |
-$171.09 M
|
$630.76 M
|
$483.66 M
|
-$82.17 M
|
$110.30 M
|
$80.85 M
|
$43.90 M
|
$28.89 M
|
| EBITDA Ratio |
-0.05 |
0.18 |
0.2 |
-0.01 |
0.07 |
-0 |
-0 |
0.17 |
| Operating Income Ratio
|
-0.19
|
0.06
|
0.09
|
0.07
|
0.06
|
-0
|
-0
|
0.01
|
| Total Other
Income/Expenses Net |
-$125.38 M
|
-$92.51 M
|
-$34.65 M
|
-$277.39 M
|
-$51.24 M
|
-$8.85 M
|
$0.00
|
-$5.76 M
|
| Income Before Tax |
-$723.78 M |
$97.90 M |
$190.96 M |
-$70.67 M |
$12.53 M |
$2.92 M |
-$693.00 |
-$3.44 M |
| Income Before Tax Ratio
|
-0.23
|
0.03
|
0.08
|
-0.07
|
0.02
|
0.01
|
-0
|
-0.02
|
| Income Tax Expense |
-$49.00 M |
$24.77 M |
$32.81 M |
-$11.96 M |
$294,000.00 |
$829,807.00 |
$248,808.00 |
$208,445.00 |
| Net Income |
-$678.90 M |
$69.32 M |
$156.18 M |
-$58.72 M |
$12.24 M |
$2.09 M |
-$693.00 |
-$3.79 M |
| Net Income Ratio |
-0.21 |
0.02 |
0.06 |
-0.06 |
0.02 |
0.01 |
-0 |
-0.02 |
| EPS |
-5.32 |
0.52 |
1.12 |
-1.12 |
0.54 |
0.0668 |
0 |
-0.121 |
| EPS Diluted |
-5.31 |
0.5 |
0.67 |
-1.12 |
0.54 |
0.0668 |
0 |
-0.121 |
| Weighted Average Shares
Out |
$134.16 M
|
$134.18 M
|
$133.03 M
|
$52.48 M
|
$22.46 M
|
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Weighted Average Shares
Out Diluted |
$134.42 M
|
$138.99 M
|
$133.03 M
|
$52.49 M
|
$22.56 M
|
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Link |
|
|
|
|
|
|
|
|
